Redbiotec AG (“Redbiotec” or “the Company”), the leader in protein complexes and designer virus-like particles (VLP), today announces two new appointments to its Scientific Advisory Board. Professor Polly Roy, one of the world’s leading baculovirus specialists, and Professor Rainer Fischer, an expert in molecular immunology and molecular biotechnology, bring extensive experience and knowledge in protein engineering and in VLP-based vaccine approaches.